A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro

Molecular Human Reproduction

Volumn 17, Issue 6, 2011, Pages 386-391

  Wang, Hui ^a   Li, Qiaoli ^b,c   Wang, Teng ^b   Yang, Guizhong ^d   Wang, Ying ^d   Zhang, Xiaoping ^d   Sang, Qing ^b   Wang, Huan ^b   Zhao, Xinzhi ^b,c   Xing, Qinghe ^b,c   Shi, Juanzi ^a   He, Lin ^b,c   Wang, Lei ^b,c  

^a Reproductive Center   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d Fourth Hospital of Xi'an City   (China)

Author keywords

Aromatase enzyme activity; CYP19A1; PCOS

Indexed keywords

ANDROSTENEDIONE; AROMATASE; ESTRONE;

ADULT; ARTICLE; CASE CONTROL STUDY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADULT; ANDROSTENEDIONE; ARGININE; AROMATASE; CASE-CONTROL STUDIES; CHINA; CYSTEINE; DNA FINGERPRINTING; ESTROGENS; ESTRONE; FEMALE; GENOTYPE; HEK293 CELLS; HUMANS; MUTATION; PLASMIDS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RISK FACTORS; TRANSFECTION;

EID: 79957449053     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gar007     Document Type: Article

References (24)

1. Ansari MA, Dhar M, Spieker S, Bakht N, Rahman AM, Moore WV, Jacobson JD. Modulation of diabetes with gonadotropin-releasing hormone antagonists in the nonobese mouse model of autoimmune diabetes. Endocrinology 2004;145:337-342.
2. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
3. Binder G, Iliev DI, Dufke A, Wabitsch M, Schweizer R, Ranke MB, Schmidt M. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. J Clin Endocrinol Metab 2005;90:484-492.
4. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005; 83:1717-1723.
5. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
6. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352: 1223-1236.
7. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the CYP19 gene. Proc Natl Acad Sci USA 1998;95:6965-6970.
8. Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem 1992;267:83-90.
9. Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet 2003;12:2679-2692.
10. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA 1993;90:11673-11677.
11. Jin JL, Sun J, Ge HJ, Cao YX, Wu XK, Liang FJ, Sun HX, Ke L, Yi L, Wu ZW et al. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. BMC Med Genet 2009;10:139.
12. Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, Dattani MT, Achermann JC. Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J Clin Endocrinol Metab 2007;92:982-990.
13. Magoffin DA. Ovarian enzyme activities in women with polycystic ovary syndrome. Fertil Steril 2006;86(suppl. 1):S9-S11.
14. Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M, Stener-Victorin E. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 2007;148:3781-3791.
15. Naessen T, Kushnir MM, Chaika A, Nosenko J, Mogilevkina I, Rockwood AL, Carlstrom K, Bergquist J, Kirilovas D. Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry. Fertil Steril 2010;94:2228-2232.
16. Ohno K, Araki N, Yanase T, Nawata H, Iida M. A novel nonradioactive method for measuring aromatase activity using a human ovarian granulosa-like tumor cell line and an estrone ELISA. Toxicol Sci 2004; 82:443-450.
17. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25.
18. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-98.
19. Soderlund D, Canto P, Carranza-Lira S, Mendez JP. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. Hum Reprod 2005;20:965-969.
20. Toda K, Terashima M, Kawamoto T, Sumimoto H, Yokoyama Y, Kuribayashi I, Mitsuuchi Y, Maeda T, Yamamoto Y, Sagara Y. Structural and functional characterization of human aromatase P-450 gene. Eur J Biochem 1990;193:559-565.
21. Turner KJ, Macpherson S, Millar MR, McNeilly AS, Williams K, Cranfield M, Groome NP, Sharpe RM, Fraser HM, Saunders PT. Development and validation of a new monoclonal antibody to mammalian aromatase. J Endocrinol 2002;172:21-30.
22. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF III, Spielman RS, Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 1999;96:8573-8578.
23. Watanabe J, Harada N, Suemasu K, Higashi Y, Gotoh O, Kawajiri K. Arginine-cysteine polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity. Pharmacogenetics 1997; 7:419-424.
24. Xita N, Lazaros L, Georgiou I, Tsatsoulis A. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype. Fertil Steril 2010; 94:250-254.